Chardan Capital Reiterates Buy on Senti Biosciences, Maintains $6 Price Target
Senti Biosciences Analyst Ratings
Chardan Capital Maintains Buy on Senti Biosciences, Lowers Price Target to $6
Morgan Stanley Adjusts Price Target on Senti Biosciences to $2 From $3, Keeps Equalweight Rating
Morgan Stanley Maintains Equal-Weight on Senti Biosciences, Lowers Price Target to $2
Morgan Stanley Reaffirms Their Hold Rating on Senti Biosciences (SNTI)
Chardan Adjusts Price Target on Senti Biosciences to $7 From $8, Keeps Buy Rating
Chardan Capital Maintains Buy on Senti Biosciences, Lowers Price Target to $7
Chardan Adjusts Senti Biosciences' Price Target to $8 From $12, Keeps Buy Rating
Senti Biosciences Analyst Ratings
Senti Biosciences (SNTI) Receives a Buy From Bank of America Securities
Senti Biosciences (SNTI) Receives a Buy From Chardan Capital
Morgan Stanley Maintains Equal-Weight on Senti Biosciences, Lowers Price Target to $3
Senti Biosciences Analyst Ratings
Senti Biosciences Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Senti Biosciences (SNTI)
Senti Biosciences Analyst Ratings
Morgan Stanley Initiates Coverage On Senti Biosciences With Equal-Weight Rating, Announces Price Target of $7.5
BofA Securities Starts Senti Biosciences at Buy With $7 Price Target
Senti Biosciences Analyst Ratings
No Data